loadpatents
name:-0.076578140258789
name:-0.029414892196655
name:-0.010994911193848
Blatt; Lawrence M. Patent Filings

Blatt; Lawrence M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blatt; Lawrence M..The latest application filed is for "conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targeting".

Company Profile
6.27.64
  • Blatt; Lawrence M. - Healdsburg CA
  • Blatt; Lawrence M. - San Mateo CA
  • Blatt; Lawrence M. - S. San Francisco CA
  • Blatt; Lawrence M - Healdsburg CA
  • Blatt; Lawrence M. - San Francisco CA
  • Blatt; Lawrence M - Brisbane CA
  • Blatt; Lawrence M. - Brisbane CA
  • Blatt; Lawrence M. - Boulder CO
  • Blatt; Lawrence M. - West Hills CA
  • Blatt; Lawrence M. - Ventura CA
  • Blatt; Lawrence M. - Sherman Oaks CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Conjugates Of S-antigen Transport Inhibiting Oligonucleotide Polymers Having Enhanced Liver Targeting
App 20220160748 - Beigelman; Leonid ;   et al.
2022-05-26
S-antigen Transport Inhibiting Oligonucleotide Polymers And Methods
App 20220125825 - Beigelman; Leonid ;   et al.
2022-04-28
S-antigen transport inhibiting oligonucleotide polymers and methods
Grant 11,166,976 - Beigelman , et al. November 9, 2
2021-11-09
Methods Of Reducing Virus Molecule Levels
App 20210230591 - Kao; Chia-Cheng ;   et al.
2021-07-29
S-antigen Transport Inhibiting Oligonucleotide Polymers And Methods
App 20210189392 - Beigelman; Leonid ;   et al.
2021-06-24
Substituted Nucleosides, Nucleotides And Analogs Thereof
App 20210106604 - Blatt; Lawrence M. ;   et al.
2021-04-15
S-antigen Transport Inhibiting Oligonucleotide Polymers And Methods
App 20200405743 - Beigelman; Leonid ;   et al.
2020-12-31
Substituted nucleosides, nucleotides and analogs thereof
Grant 10,780,105 - Blatt , et al. Sept
2020-09-22
S-antigen Transport Inhibiting Oligonucleotide Polymers And Methods
App 20200147124 - Beigelman; Leonid ;   et al.
2020-05-14
Substituted nucleosides, nucleotides and analogs thereof
Grant 10,307,439 - Blatt , et al.
2019-06-04
Substituted Nucleosides, Nucleotides And Analogs Thereof
App 20190054108 - Blatt; Lawrence M. ;   et al.
2019-02-21
Substituted nucleosides, nucleotides and analogs thereof
Grant 10,052,342 - Blatt , et al. August 21, 2
2018-08-21
Method of modulating stress-activated protein kinase system
Grant 10,010,536 - Blatt , et al. July 3, 2
2018-07-03
Methods For Treating Respiratory Syncytial Virus Infection
App 20180117042 - CHANDA; Sushmita Mukherjee ;   et al.
2018-05-03
Combination Therapy Regimen For Treatment Of Selected HCV Genotypes
App 20180021360 - Beumont; Maria Gloria ;   et al.
2018-01-25
Combination Drug Treatment For Hepatitis C Infection
App 20180021361 - Beumont; Maria Gloria ;   et al.
2018-01-25
Combination Drug Treatment For Hepatitis C Infection
App 20170319572 - Beumont; Maria Gloria ;   et al.
2017-11-09
Substituted Nucleosides, Nucleotides And Analogs Thereof
App 20170143751 - Blatt; Lawrence M. ;   et al.
2017-05-25
Substituted Nucleosides, Nucleotides And Analogs Thereof
App 20170143749 - Blatt; Lawrence M. ;   et al.
2017-05-25
Method Of Modulating Stress-activated Protein Kinase System
App 20170095462 - Blatt; Lawrence M. ;   et al.
2017-04-06
Combination Therapy Regimen For Treatment Of Hcv
App 20170087174 - Beumont; Maria Gloria ;   et al.
2017-03-30
Substituted nucleosides, nucleotides and analogs thereof
Grant 9,603,863 - Blatt , et al. March 28, 2
2017-03-28
Substituted nucleosides, nucleotides and analogs thereof
Grant 9,603,864 - Blatt , et al. March 28, 2
2017-03-28
Method of modulating stress-activated protein kinase system
Grant 9,527,816 - Blatt , et al. December 27, 2
2016-12-27
Hepatitis C viral infection treatment using a combination of compounds
Grant 9,504,705 - Krop , et al. November 29, 2
2016-11-29
Combination Therapy For Treating A Paramyxovirus
App 20160045528 - Blatt; Lawrence M. ;   et al.
2016-02-18
Methods For Treating Paramyxoviruses
App 20160022724 - Chanda; Sushmita Mukherjee ;   et al.
2016-01-28
Substituted Nucleosides, Nucleotides And Analogs Thereof
App 20150366888 - Blatt; Lawrence M. ;   et al.
2015-12-24
Substituted Nucleosides, Nucleotides And Analogs Thereof
App 20150366887 - Blatt; Lawrence M. ;   et al.
2015-12-24
Pharmaceutical combinations comprising a thionucleotide analog
Grant 9,012,427 - Blatt , et al. April 21, 2
2015-04-21
Hepatitis C Viral Infection Treatment Using A Combination Of Compounds
App 20140303113 - Krop; Julie ;   et al.
2014-10-09
Method Of Modulating Stress-activated Protein Kinase System
App 20140228310 - Blatt; Lawrence M. ;   et al.
2014-08-14
Method of modulating stress-activated protein kinase system
Grant 8,741,936 - Blatt , et al. June 3, 2
2014-06-03
Pharmaceutical Combinations Comprising A Thionucleotide Analog
App 20130252920 - Blatt; Lawrence M. ;   et al.
2013-09-26
Macrocyclic inhibitors of hepatitis C virus replication
Grant 8,299,021 - Blatt , et al. October 30, 2
2012-10-30
Method Of Modulating Stress-activated Protein Kinase System
App 20120258924 - Blatt; Lawrence M. ;   et al.
2012-10-11
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
App 20120208995 - Blatt; Lawrence M. ;   et al.
2012-08-16
Methods Of Treating Atrial Fibrillation With P38 Inhibitor Compounds
App 20120046321 - Olgin; Jeff ;   et al.
2012-02-23
Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia
App 20110218169 - Phillips; Roderick ;   et al.
2011-09-08
Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections
App 20110177026 - Blatt; Lawrence M. ;   et al.
2011-07-21
Use of .alpha.-glucosidase inhibitors to treat alphavirus infections
Grant 7,932,267 - Blatt , et al. April 26, 2
2011-04-26
Peptide inhibitors of hepatitis C virus replication
Grant 7,932,277 - Seiwert , et al. April 26, 2
2011-04-26
Hyperglycosylated Polypeptide Variants And Methods Of Use
App 20110008289 - BLATT; LAWRENCE M. ;   et al.
2011-01-13
Macrocyclic inhibitors of hepatitis C virus replication
Grant 7,829,665 - Blatt , et al. November 9, 2
2010-11-09
Method Of Modulating Stress-activated Protein Kinase System
App 20100240704 - Blatt; Lawrence M. ;   et al.
2010-09-23
Inhibitors of hepatitis C virus replication
Grant 7,781,474 - Seiwert , et al. August 24, 2
2010-08-24
Novel Inhibitors Of Hepatitis C Virus Replication
App 20100209391 - SEIWERT; SCOTT ;   et al.
2010-08-19
Use Of Alpha-glucosidase Inhibitors To Treat Alphavirus Infections
App 20100150867 - BLATT; Lawrence M. ;   et al.
2010-06-17
Method of modulating stress-activated protein kinase system
Grant 7,728,013 - Blatt , et al. June 1, 2
2010-06-01
Synthetic Hyperglycosylated, Protease-resistant Polypeptide Variants, Oral Formulations And Methods Of Using The Same
App 20100099851 - Hong; Jin ;   et al.
2010-04-22
Methods of Treating Atrial Fibrillation with P38 Inhibitor Compounds
App 20100029578 - Olgin; Jeff ;   et al.
2010-02-04
Use of alpha-glucosidase inhibitors to treat alphavirus infections
Grant 7,638,488 - Blatt , et al. December 29, 2
2009-12-29
Novel Peptide Inhibitors Of Hepatitis C Virus Replication
App 20090297476 - SEIWERT; SCOTT ;   et al.
2009-12-03
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090286843 - BLATT; LAWRENCE M. ;   et al.
2009-11-19
Hyperglycosylated polypeptide variants and methods of use
Grant 7,597,884 - Blatt , et al. October 6, 2
2009-10-06
Continuous Delivery Methods For Treating Hepatitis Virus Infection
App 20090226400 - Blatt; Lawrence M. ;   et al.
2009-09-10
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
App 20090169510 - Blatt; Lawrence M ;   et al.
2009-07-02
Pirfenidone/toll-like Receptor (tlr) Agonist Compositions And Methods For Using Them To Stimulate Production Of Granulocyte Colonizing Stimulating Factor (g-csf)
App 20090170804 - Phillips; Roderick ;   et al.
2009-07-02
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication
App 20090155209 - BLATT; LAWRENCE M. ;   et al.
2009-06-18
Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
App 20090148407 - Blatt; Lawrence M. ;   et al.
2009-06-11
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090111982 - Blatt; Lawrence M. ;   et al.
2009-04-30
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090111969 - Blatt; Lawrence M. ;   et al.
2009-04-30
Macrocyclic Compounds As Inhibitors Of Viral Replication
App 20090105471 - Blatt; Lawrence M. ;   et al.
2009-04-23
Compositions And Methods For Treating Coronavirus Infection And Sars
App 20090068142 - BLATT; Lawrence M.
2009-03-12
Novel Inhibitors Of Hepatitis C Virus Replication
App 20090047246 - Beigelman; Leonid ;   et al.
2009-02-19
Macrocyclic compounds as inhibitors of viral replication
Grant 7,491,794 - Blatt , et al. February 17, 2
2009-02-17
2-5A Analogs and their Methods of Use
App 20080207554 - Beigelman; Leonid ;   et al.
2008-08-28
Use of pirfenidone in therapeutic regimens
Grant 7,407,973 - Ozes , et al. August 5, 2
2008-08-05
Methods of Treating Tnf-Mediated Disorders
App 20080025986 - Ozes; Osman N. ;   et al.
2008-01-31
Novel Inhibitors Of Hepatitis C Virus Replication
App 20080019942 - Seiwert; Scott ;   et al.
2008-01-24
High Throughput Collagen Synthesis Assay
App 20080003635 - Ozes; Osman Nidai ;   et al.
2008-01-03
Combination Therapy for Treating Hepatitis C Virus Infection
App 20070258946 - Blatt; Lawrence M.
2007-11-08
Synthetic chemokine receptor ligands and methods of use thereof
App 20070172446 - Blatt; Lawrence M.
2007-07-26
Compositions and methods for treating poxvirus infection
App 20070154454 - Murphy; Brian ;   et al.
2007-07-05
Use of pirfenidone in therapeutic regimens
App 20070117841 - Ozes; Osman N. ;   et al.
2007-05-24
Continuous delivery methods for treating hepatitis virus infection
App 20070077225 - Blatt; Lawrence M. ;   et al.
2007-04-05
Combination therapy for treating alphavirus infection and liver fibrosis
App 20070072181 - Blatt; Lawrence M.
2007-03-29
Novel macrocyclic inhibitors of hepatitis C virus replication
App 20070054842 - Blatt; Lawrence M. ;   et al.
2007-03-08
Combination therapy for cancer treatment
App 20070032457 - Blatt; Lawrence M.
2007-02-08
Method of modulating stress-activated protein kinase system
App 20060270612 - Blatt; Lawrence M. ;   et al.
2006-11-30
Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same
App 20060204473 - Blatt; Lawrence M. ;   et al.
2006-09-14
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
App 20060182716 - Hong; Jin ;   et al.
2006-08-17
Interferon compositions and methods of use thereof
App 20060018875 - Blatt; Lawrence M. ;   et al.
2006-01-26
Macrocyclic compounds as inhibitors of viral replication
App 20050267018 - Blatt, Lawrence M. ;   et al.
2005-12-01
Compositions and methods for treating coronavirus infection and SARS
App 20050002901 - Blatt, Lawrence M.
2005-01-06
Use of the human interferon consensus gene for gene therapy
Grant 5,831,062 - Taylor , et al. November 3, 1
1998-11-03
Bioconversions catalysed by the toluene monooxygenase of Pseudomonas mendocinaKR-1
Grant 5,605,823 - Yen , et al. February 25, 1
1997-02-25
Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
Grant 5,372,808 - Blatt , et al. December 13, 1
1994-12-13
Bioconversions catalyzed by the toluene monooxygenase of Pseudomanas mendocina KR-1
Grant 5,171,684 - Yen , et al. * December 15, 1
1992-12-15
Plasmid encoding the Pseudomonas mendocina toluene monooxygenase gene
Grant 5,017,495 - Yen , et al. May 21, 1
1991-05-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed